Join DS2 at Clinical Trial Supply West Coast 2026
Two days in Burlingame, September 22 and 23. Our team is sitting in the program and keeping the breaks free for customers, partners and anyone who wants to talk clinical supply. Book a slot.
Let's Connect in Burlingame
Around two hundred clinical supply chain, packaging, logistics, procurement and quality leaders from California pharma and biotech gather here, and this is the community DS2 works with every day. We are looking forward to two days of conversation about the work itself. We would love to hear from you if you are choosing a kitting and distribution partner, planning ancillary or comparator supply, building cold chain you can evidence with confidence, or bringing samples back from participants at home. We're ready to get into volumes, lead times and lanes whenever you are.
We often find during these events that the diary fills up quickly. Use the form and we'll block a time for you to meet our team while availability lasts.
Why Attend Clinical Trial Supply West Coast 2026?
Arena International bills this as the main gathering for the Californian pharma and biotech clinical supply community, under the line Solving the Global Clinical Supply Puzzle. Two days of presentations, interactive roundtables and expert panels, built for people who own the supply chain rather than talk about it.
Intentionally small: Around 200 attendees, 25 exhibitors and 20 speakers, with roughly 80% at C-suite level, which is a very different room from a five-thousand-person show.
Regulators on the program: The FDA's Division of West Coast Imports opens day one, and U.S. Customs and Border Protection run both a roundtable and a spotlight on duty and entry rates.
This year's streams: Stream headers this year cover end-to-end supply excellence, geopolitics and transatlantic alignment, the trade-off between velocity, precision and cost, strategic partnerships, compliance and quality, patient-centered design, and the biotech frontier.
Why Meet with DS2?
DS2 is a clinical and diagnostic logistics business. Kits built and shipped, specimens moved and stored, temperature held and evidenced, and the data connected back to the systems that need it. Sponsors call us in when the supply chain has quietly become someone's full-time job. What we do:
- Diagnostic and specimen collection kit design, assembly and fulfillment
- Kit-to-patient and direct-to-patient distribution
- Medical courier services, including STAT and next-flight-out specimen transport
- Cold chain and temperature-controlled logistics, with the documentation to prove the range held
- Biostorage and biorepository services
- Mobile phlebotomy and specimen collection
- LIS, LIMS and EMR integration, including HL7 and FHIR
- Chain of custody and compliance documentation
Whether you need kitting, ancillary supply and specimen return handled separately or as one package, we're looking forward to talking it through in Burlingame.
Some of Who Is Speaking
Drawn from the published faculty:
Jessica Lee and Marissa Chan
Division of West Coast Imports, FDA
Supervisory Consumer Safety Officers
Brandy Porter
U.S. Customs and Border Protection
Assistant Center Director, Enforcement, Pharmaceuticals, Health and Chemicals
Shubhra Kochar
Genentech
Head of Global Clinical Supply Chain Planning
Jamie Goldman
Orca Bio
Logistics Program Manager, on using AI to protect patient delivery
Nick Vyas
USC Marshall School of Business
Professor, Clinical Data Sciences and Supply Chain Operations
Chris Driver
IQVIA Technologies
Senior Director, Product Management, AI and Technology Solutions
M. David Malenfant
TCU
Executive supply chain leader and mentor, chairing day two
Christine von Raesfeld
The Light Collective
Patient Advocate
Paul Hingst
Crinetics Pharmaceuticals
Supply Chain Consultant
Sebastian De Beurs
Healis Therapeutics
Co-Founder, on China's biotechnology sector
The full speaker list sits on the official event page.
The Agenda, Day by Day
Two streams run through the middle of each day. Sessions move. Check the official agenda before you build your schedule.
Day One · Tuesday, September 22, 2026
Registration and refreshments
Chairperson's opening remarks
Opening regulatory keynote: Ensuring Clinical Trial Continuity, navigating the importation of pharmaceuticals, biologics, medical devices and combination products
Jessica Lee and Marissa Chan, FDA Division of West Coast Imports
The Forecast Is Dead: clinical supply's shift from prediction to continuous orchestration
Chris Driver, IQVIA Technologies
Geo spotlight: Shocks, Shifts, and Safeguards, new principles for supply chain stability
Nick Vyas, USC Marshall School of Business
From Concept to Clinic: operationalizing the pharmacy card model to decentralize supply
Tom Gottschalk, Valeris
Morning refreshments and networking
Panel: choosing CDMOs as a true extension of your team
Moderated by Amanda Murphy, GlobalData, with Sutro Biopharma, Sangamo Therapeutics and 89bio
Case study: streamlining end-to-end supply complexity with S&OP governance
Monica Eris, formerly Imugene Limited
Inside the CDMO and biotech collaboration / making planning work through people, process and performance
Thermo Fisher Scientific and 4D Molecular Therapeutics · N-SIDE
Trial and drug complexity reshaping supply chain strategy / aligning demand planning and execution
GlobalData · Praxis Precision Medicines, Genentech, IQVIA and N-SIDE
Lunch and networking
Managing drug waste through the clinical trial lifecycle
Shubhra Kochar, Genentech
Fireside chat: the silo effect, turning disconnected functions into one strategy
Attovia Therapeutics, TCU and BeOne Medicines
The 72-Hour Pulse: how Orca Bio is using AI to erase risk and guarantee patient delivery
Jamie Goldman, Orca Bio
Afternoon refreshments and networking
Interactive boardroom: AI with a Human Touch, practical strategies for smart, safe adoption
Sia Zadeh, Golden Gate University
Chair's summary and close of day one
Drinks reception and prize draw
Day Two · Wednesday, September 23, 2026
Registration and refreshments
Chair's opening remarks
M. David Malenfant, TCU
Hosted breakfast roundtables
US biological material importation with U.S. Customs and Border Protection; small vs large CDMOs; big pharma standards on a startup budget; AI in daily workflows; integrated program planning; people, process and tech
Fireside chat: staying GMP and GCP compliant while optimizing resources
Crinetics Pharmaceuticals, Prometheus Therapeutics and Grail
From audit nightmares to real-time accountability and audit readiness
Paul Hingst, Crinetics Pharmaceuticals
Morning refreshments and networking
Patient advocacy interview: how every operational decision reaches the patient
Christine von Raesfeld, The Light Collective, with Paul Gater
Industry debate: the road to patient-centric trials
Regulatory spotlight: duty and entry rates in US clinical supply chain imports
Brandy Porter, U.S. Customs and Border Protection
Lunch, networking and prize draw
Keynote: China's biotechnology sector and what it means for America
Sebastian De Beurs, Healis Therapeutics
Biotech hot takes: short talks from industry leaders
End of conference
Clinical Trial Supply West Coast 2026 FAQ
General
Registration & travel
See You in Burlingame
September 22 and 23, Hyatt Regency San Francisco Airport. Tell us the problem you are trying to solve and we will keep a break free.